Literature DB >> 14616164

How patients manage gastrointestinal symptoms after pelvic radiotherapy.

B Gami1, K Harrington, P Blake, D Dearnaley, D Tait, J Davies, A R Norman, H J N Andreyev.   

Abstract

BACKGROUND: Approximately 13,000 patients undergo pelvic radiotherapy annually in the UK. It is not clear how frequently patients develop a permanent change in bowel habit after pelvic radiotherapy that affects their quality of life because the measures of gastrointestinal toxicity used in trials in the past have generally been inadequate. It has been suggested that patients who are symptomatic are only rarely referred to a gastroenterologist and it is not known how patients manage their symptoms.
METHODS: Patients who had completed radiotherapy for pelvic cancer at least 1 year previously were invited to answer 30 structured questions in a face-to-face interview to determine the frequency of gastrointestinal symptoms and what orthodox, dietary and complementary therapies they used to deal with them. They were also asked to score the effectiveness of the measures they had taken.
RESULTS: One hundred and seven patients were recruited [35 males; median age, 65 years (range, 35-80 years); 72 females; median age, 67.5 years (range, 31-87 years)]. Eight had been treated for a gastrointestinal primary tumour, 34 for a urological tumour and 65 for gynaecological tumours. Eighty-seven patients (81%) described new-onset gastrointestinal problems starting after radiotherapy. These symptoms affected the quality of life in 56 patients (52%). Significant effects on the quality of life were caused by diarrhoea or constipation (n = 53), faecal leakage (n = 19), abdominal, rectal or perineal pain (n = 14) and rectal bleeding (n = 6). Fifty-nine patients had seen a doctor for their symptoms (86% found this helpful), 12 had seen a dietician or nurse (50% found this helpful) and 14 had seen alternative practitioners (88% found this helpful). Dietary manipulation generally did not improve symptoms, except in a small group of patients (14/15) who avoided raw vegetables to great benefit.
CONCLUSIONS: At least 1 year after pelvic radiotherapy, gastrointestinal symptoms which have an adverse effect on the quality of life may be more common than generally reported. Patients found that advice from doctors and alternative practitioners was equally valuable. Dietary manipulation was generally unhelpful for gastrointestinal symptoms after pelvic radiotherapy, although the role of eliminating raw vegetables may benefit from further evaluation.

Entities:  

Mesh:

Year:  2003        PMID: 14616164     DOI: 10.1046/j.1365-2036.2003.01760.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  39 in total

1.  Pain in cancer survivors.

Authors:  Matthew Rd Brown; Juan D Ramirez; Paul Farquhar-Smith
Journal:  Br J Pain       Date:  2014-11

2.  Gastrointestinal complications of pelvic radiotherapy: are they of any importance?

Authors:  J Andreyev
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

Review 3.  Managing gastrointestinal symptoms after cancer treatment: a practical approach for gastroenterologists.

Authors:  Ann C Muls; Lorraine Watson; Clare Shaw; H Jervoise N Andreyev
Journal:  Frontline Gastroenterol       Date:  2012-10-02

Review 4.  Radiation-induced small bowel disease: latest developments and clinical guidance.

Authors:  Rhodri Stacey; John T Green
Journal:  Ther Adv Chronic Dis       Date:  2014-01       Impact factor: 5.091

5.  Practical approaches to effective management of intestinal radiation injury: benefit of resectional surgery.

Authors:  Nikolaos Perrakis; Evangelos Athanassiou; Dimitra Vamvakopoulou; Maria Kyriazi; Haris Kappos; Nikolaos C Vamvakopoulos; Iakovos Nomikos
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

6.  Radiation enteritis leading to intestinal failure: 1994 patient-years of experience in a national referral centre.

Authors:  R Kalaiselvan; V S Theis; M Dibb; A Teubner; I D Anderson; J L Shaffer; G L Carlson; S Lal
Journal:  Eur J Clin Nutr       Date:  2013-12-11       Impact factor: 4.016

7.  Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients.

Authors:  Imjai Chitapanarux; Taned Chitapanarux; Patrinee Traisathit; Sudkaneung Kudumpee; Ekkasit Tharavichitkul; Vicharn Lorvidhaya
Journal:  Radiat Oncol       Date:  2010-05-05       Impact factor: 3.481

Review 8.  Gastrointestinal radiation injury: symptoms, risk factors and mechanisms.

Authors:  Abobakr K Shadad; Frank J Sullivan; Joseph D Martin; Laurence J Egan
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

Review 9.  Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys.

Authors:  Paul Posadzki; Leala K Watson; Amani Alotaibi; Edzard Ernst
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

Review 10.  The challenges of colorectal cancer survivorship.

Authors:  Crystal S Denlinger; Andrea M Barsevick
Journal:  J Natl Compr Canc Netw       Date:  2009-09       Impact factor: 11.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.